Cytodyn Inc (CYDY)

[misiu143]

Ibalizumab is imo not superior to Pro 140, intravenous infusions every 2 weeks is not even a competition to self given SC injection every week .
In IV treatment about 36% of patient developed viral load
<50 copies/ml. I believe we see better results with Pro 140.

There study for IM and SC injection are very early ,
Phase 1 for HIV positive patients and Phase 2 for HIV negative , given as a prevention. Both done in Taiwan .

How you came up that CYDY needing 100 mill for there study , that is not what Dr P is saying , and that they need two Phase 3 study for monotherapy , well this is also wrong information.